Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer - Chemosensitivity test and a comparative study with doxorubicin

T. Nakashima, A. Masuda, G. Yano, Y. Maehara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The chemosensitivities of 77 samples of human head and neck cancer were examined by in vitro succinate dehydrogenase inhibition (SDI) test. The tumor tissues obtained at biopsy specimens were exposed to doxorubicin (DXR) and pirarubicin (THP). The average decrease of the enzyme activity by THP was significantly greater than that by DXR. In 60 cases of squamous cell carcinomas, the chemosensitivity of poorly differentiated type tended to be higher compared to the well differentiated type. It is suggested from there results that THP is a more effective anticancer drug than DXR against human head and neck cancers. Clinically good responses were obtained in a systemic chemotherapy of such as head and neck adenoid cystic carcinomas by combining THP with other anticancer drugs such as CDDP (or CBDCA) and CPA.

Original languageEnglish
Pages (from-to)633-639
Number of pages7
JournalJapanese Journal of Cancer and Chemotherapy
Volume21
Issue number5
Publication statusPublished - Jan 1 1994

Fingerprint

Head and Neck Neoplasms
Doxorubicin
Adenoid Cystic Carcinoma
Succinate Dehydrogenase
Carboplatin
Pharmaceutical Preparations
Squamous Cell Carcinoma
Neck
Head
Biopsy
Drug Therapy
Enzymes
Neoplasms
pirarubicin
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer - Chemosensitivity test and a comparative study with doxorubicin. / Nakashima, T.; Masuda, A.; Yano, G.; Maehara, Y.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 21, No. 5, 01.01.1994, p. 633-639.

Research output: Contribution to journalArticle

@article{e2aa6c893e2f488abdb5dead36ae7836,
title = "Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer - Chemosensitivity test and a comparative study with doxorubicin",
abstract = "The chemosensitivities of 77 samples of human head and neck cancer were examined by in vitro succinate dehydrogenase inhibition (SDI) test. The tumor tissues obtained at biopsy specimens were exposed to doxorubicin (DXR) and pirarubicin (THP). The average decrease of the enzyme activity by THP was significantly greater than that by DXR. In 60 cases of squamous cell carcinomas, the chemosensitivity of poorly differentiated type tended to be higher compared to the well differentiated type. It is suggested from there results that THP is a more effective anticancer drug than DXR against human head and neck cancers. Clinically good responses were obtained in a systemic chemotherapy of such as head and neck adenoid cystic carcinomas by combining THP with other anticancer drugs such as CDDP (or CBDCA) and CPA.",
author = "T. Nakashima and A. Masuda and G. Yano and Y. Maehara",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "21",
pages = "633--639",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "5",

}

TY - JOUR

T1 - Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer - Chemosensitivity test and a comparative study with doxorubicin

AU - Nakashima, T.

AU - Masuda, A.

AU - Yano, G.

AU - Maehara, Y.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The chemosensitivities of 77 samples of human head and neck cancer were examined by in vitro succinate dehydrogenase inhibition (SDI) test. The tumor tissues obtained at biopsy specimens were exposed to doxorubicin (DXR) and pirarubicin (THP). The average decrease of the enzyme activity by THP was significantly greater than that by DXR. In 60 cases of squamous cell carcinomas, the chemosensitivity of poorly differentiated type tended to be higher compared to the well differentiated type. It is suggested from there results that THP is a more effective anticancer drug than DXR against human head and neck cancers. Clinically good responses were obtained in a systemic chemotherapy of such as head and neck adenoid cystic carcinomas by combining THP with other anticancer drugs such as CDDP (or CBDCA) and CPA.

AB - The chemosensitivities of 77 samples of human head and neck cancer were examined by in vitro succinate dehydrogenase inhibition (SDI) test. The tumor tissues obtained at biopsy specimens were exposed to doxorubicin (DXR) and pirarubicin (THP). The average decrease of the enzyme activity by THP was significantly greater than that by DXR. In 60 cases of squamous cell carcinomas, the chemosensitivity of poorly differentiated type tended to be higher compared to the well differentiated type. It is suggested from there results that THP is a more effective anticancer drug than DXR against human head and neck cancers. Clinically good responses were obtained in a systemic chemotherapy of such as head and neck adenoid cystic carcinomas by combining THP with other anticancer drugs such as CDDP (or CBDCA) and CPA.

UR - http://www.scopus.com/inward/record.url?scp=0028213388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028213388&partnerID=8YFLogxK

M3 - Article

C2 - 8154889

AN - SCOPUS:0028213388

VL - 21

SP - 633

EP - 639

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 5

ER -